BAUPOST GROUP LLC/MA
Q1 2014 13F-HR Holdings
Net value change ($000)
+607,733
(17.2%)
New positions
4
Sold out positions
3
Turnover %
15.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LNG | 313,281 | NEW |
| KERYX BIOPHARMACEUTICALS | 107,537 | NEW |
| MU | 98,662 | 8.8% |
| VSAT | 89,529 | 12.8% |
| IDENIX PHARMACEUTICALS INC | 82,117 | 37.2% |
| PBF | 77,564 | 124.7% |
| RF MICRODEVICES INC | 51,890 | NEW |
| TRIQUINT SEMICONDUCTOR INC COM | 51,217 | NEW |
| NG | 23,207 | 42.1% |
| Kindred Biosciences, Inc. | 18,821 | 58.1% |
Top Reduces (Value $000, Stocks/ETFs)
| BP | -123,140 | -44.7% |
| THERAVANCE INC | -77,507 | -10.8% |
| FNF | -64,069 | -100.0% |
| Rovi Corp | -42,530 | -100.0% |
| ENZN | -5,032 | -100.0% |
| AVEO PHARMACEUTICALS, INC. | -1,283 | -18.3% |
| NOVACOPPER INC | -851 | -11.2% |
| ALLIANCE ONE INTL | -830 | -4.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|